Effects of a Gluten-Free Diet in Patients With Type 1 Diabetes and Asymptomatic Celiac Disease
In individuals with type 1 diabetes who test positive for asymptomatic celiac disease, a gluten-free diet may increase postprandial glycemic levels.
Type 1 Diabetes
Regional Variation in the Management of Diabetes in the United States
In national patient registries, cardiovascular disease risk and diabetes management varied by geographic region in the United States.
Recommendations for Effective Implementation of Telehealth for Diabetes Care
Experts provide recommendations for effective implementation of telehealth for diabetes care, with a focus on patient-to-clinic video encounters.
COVID-19 Outcomes Worse With Diabetes, Hyperglycemia
Diabetes and/or uncontrolled hyperglycemia occur frequently among hospitalized patients with COVID-19 and are associated with worse outcomes.
Nonglycemic Factors Increase Risk for Peripheral Neuropathy in T1D
Several nonglycemic factors may increase the risk for the development of diabetic peripheral neuropathy (DPN) among people with type 1 diabetes.
Telemedicine for Diabetes Management During the COVID-19 Pandemic and Beyond
Changes to restrictions for telemedicine may have important implications for the management of adult and pediatric diabetes during the COVID-19 pandemic.
Risk Factors Differ by First Cardiovascular Disease Manifestations in Type 1 Diabetes
Researchers found that risk factors differ between various first manifestations of cardiovascular disease in patients with type 1 diabetes.
Authorized Generics of Insulin Lispro Products Now Available
Lilly announced the availability of lower-priced, non-branded versions of Humalog® Mix75/25™ KwikPen® and Humalog® Junior KwikPen®.
Effects of COVID-19 on Treatment Choice for Type 2 Diabetes
COVID-19 may affect treatment for patients with type 2 diabetes and necessitates re-evaluation of medications based on existing evidence.
Novo Nordisk Launches Insulin Program for Patients Affected Financially by COVID-19 Pandemic
Novo Nordisk has launched its Diabetes Patient Assistance Program in response to the COVID-19 pandemic for patients with diabetes who have lost health insurance coverage due to a change in job status.
Next post in Diabetes
